Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
Aim. То study 12-week spirapril (Quadropril®) therapy effectiveness in patients with mild to moderate arterial hypertension (АП). Material and metliods. For 12 weeks, 62 patients with mild to moderate АП received spirapril (6 mg/d), with diuretics (hydrochlorthiazide or Arifon retard) added if antih...
Main Authors: | M. M. Beraya, V. V. Petriy, N. G. Sergushkina, V. I. Makolkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1527 |
Similar Items
-
Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
by: M. M. Beraya, et al.
Published: (2007-02-01) -
ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01) -
Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2007-08-01) -
Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01) -
SPIRAPRIL EFFECTS ON OFFICE AND AMBULATORY BLOOD PRESSURE LEVELS AND THEIR DIFFERENCE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2009-02-01)